Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Patent
1988-11-03
1990-05-22
Shippen, Michael L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
560137, 560145, 560159, 560168, 560169, 562555, C07C12912, C07C125065
Patent
active
049279653
ABSTRACT:
Compounds having the formula: ##STR1## wherein R.sup.1 is --NH(C.dbd.O)OR.sup.5, --NH(C.dbd.NH)NH.sub.2 or --NH(C.dbd.N--NO.sub.2)HN.sub.2 ; R.sup.2 is hydrogen, C.sub.1-8 alkyl or C.sub.6-8 aryl; n is 2 to 6; and R.sup.5 is hydrogen,
REFERENCES:
patent: 4228184 (1980-10-01), Ondetti
patent: 4418075 (1983-11-01), Tamai
Osteolytic Bone Metastases in Breast Carcinoma Pathogenesis, Morbidity and Bisphosphonate Treatment, Elte et al., Pergamon Prfess (1986), pp. 493-500.
Biochemical and Histomorphometric Characterization of a Rat Model for Humoral Hypercalcemia of Malignancy, Insogna et al., Endocrinology, vol. 114, No. 3, pp. 888-896.
The Hypercalcemic Rat Leydig Cell Tumor-a Model of the Humoral Hypercalcemia of Malginance, Sica et al., Calc. Tiss. Internatl., (1983), 35, pp. 287-293.
Comparison of Two Parenteral Diphosphonates in Hypercalcemia of Malignancy, A. Jung, Amer. J. of Med., vol. 72, pp. 221-226.
Effects of Disodium Dichloromethylene Diphosphonate on Hypercalcemia Produced by Bone Metastases, Chapuy et al., J. Clin. Invest., vol. 65, (1980), 1243-1247.
The Effects of Dichloromethylene Diphosphonate on Hypercalcemia and Other Parameters of the Humoral Hypercalcemia of Malig. in the Rat Leydig Cell Tumor, Martodam et al., Calc. Tiss. Internatl., (1983), 35: 512-519.
L-Trans-Epoxysuccinyl-Leucylamido (4-Guanidino)Butane(E-64) and its Analogues as Inhibitors of Cysteine Proteinases Including Cathespsins B, H, and L. Barrett et al., Biochem. J. (1982), 201, pp. 189-198.
In Vivo and In Vitro Evidence for the Involvement of Cysteine Proteinases in Bone Resorption, Delaisse et al., Biochem. and Biophysical Res. Comm., vol. 125, No. 2, 1984, pp. 441-447.
The Cysteine Protease Inhibitor, E-64, Stimulates the Polarization and Locomotor Responses of Endothelial Cells to Wounding, Eilon et al., The Jornl. of Phar. & Exp. Therp., vol. 24, No. 1, pp. 361-367 (1988).
Eilon Gabriel F.
Thompson Wayne J.
Caruso Charles M.
Harbour John W.
Merck & Co. , Inc.
Shippen Michael L.
LandOfFree
N-(N-succinyl-L-leucyl)agmatine, related compounds and use in ph does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(N-succinyl-L-leucyl)agmatine, related compounds and use in ph, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(N-succinyl-L-leucyl)agmatine, related compounds and use in ph will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2136127